>AT1G12460.1 | leucine-rich repeat transmembrane protein kinase putative
MRKVHLFLVLVHFIYISTSRSDSISERDILLQFKGSISDDPYNSLASWVSDGDLCNSFNG
ITCNPQGFVDKIVLWNTSLAGTLAPGLSNLKFIRVLNLFGNRFTGNLPLDYFKLQTLWTI
NVSSNALSGPIPEFISELSSLRFLDLSKNGFTGEIPVSLFKFCDKTKFVSLAHNNIFGSI
PASIVNCNNLVGFDFSYNNLKGVLPPRICDIPVLEYISVRNNLLSGDVSEEIQKCQRLIL
VDLGSNLFHGLAPFAVLTFKNITYFNVSWNRFGGEIGEIVDCSESLEFLDASSNELTGRI
PTGVMGCKSLKLLDLESNKLNGSIPGSIGKMESLSVIRLGNNSIDGVIPRDIGSLEFLQV
LNLHNLNLIGEVPEDISNCRVLLELDVSGNDLEGKISKKLLNLTNIKILDLHRNRLNGSI
PPELGNLSKVQFLDLSQNSLSGPIPSSLGSLNTLTHFNVSYNNLSGVIPPVPMIQAFGSS
AFSNNPFLCGDPLVTPCNSRGAAAKSRNSDALSISVIIVIIAAAVILFGVCIVLALNLRA
RKRRKDEEILTVETTPLASSIDSSGVIIGKLVLFSKNLPSKYEDWEAGTKALLDKENIIG
MGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEQEIGRLGGLQHPNLSSFQGYYFSS
TMQLILSEFVPNGSLYDNLHLRIFPGTSSSYGNTDLNWHRRFQIALGTAKALSFLHNDCK
PAILHLNVKSTNILLDERYEAKLSDYGLEKFLPVMDSFGLTKKFHNAVGYIAPELAQQSL
RASEKCDVYSYGVVLLELVTGRKPVESPSENQVLILRDYVRDLLETGSASDCFDRRLREF
EENELIQVMKLGLLCTSENPLKRPSMAEVVQVLESIRNGFGS*
>AT5G59680.1 | leucine-rich repeat protein kinase putative
MERSLELLLLLIRTLAIIHISQAQSQQGFISLDCGLPANEPSPYTEPRTGLQFSSDAAFI
QSGKIGRIQANLEADFLKPSTTMRYFPDGKRNCYNLNVEKGRNHLIRARFVYGNYDGRDT
GPKFDLYLGPNPWATIDLAKQVNGTRPEIMHIPTSNKLQVCLVKTGETTPLISVLEVRPM
GSGTYLTKSGSLKLYYREYFSKSDSSLRYPDDIYDRQWTSFFDTEWTQINTTSDVGNSND
YKPPKVALTTAAIPTNASAPLTNEWSSVNPDEQYYVYAHFSEIQELQANETREFNMLLNG
KLFFGPVVPPKLAISTILSVSPNTCEGGECNLQLIRTNRSTLPPLLNAYEVYKVIQFPQL
ETNETDVSAVKNIQATYELSRINWQSDPCVPQQFMWDGLNCSITDITTPPRITTLNLSSS
GLTGTITAAIQNLTTLEKLDLSNNNLTGEVPEFLSNMKSLLVINLSGNDLNGTIPQSLQR
KGLELLYQGNPRLISPGSTETKSGKSFPVTIVASVGSAAILIVVLVLVLFLRKKKPSAVE
VVLPRPSRPTMNVPYANSPEPSIEMKKRKFTYSEVTKMTNNFGRVVGEGGFGVVCHGTVN
GSEQVAVKLLSQSSTQGYKEFKAEVDLLLRVHHTNLVSLVGYCDEGDHLALIYEFVPNGD
LRQHLSGKGGKPIVNWGTRLRIAAEAALGLEYLHIGCTPPMVHRDVKTTNILLDEHYKAK
LADFGLSRSFPVGGESHVSTVIAGTPGYLDPDRLSEKSDVYSFGIVLLEMITNQAVIDRN
RRKSHITQWVGSELNGGDIAKIMDLKLNGDYDSRSAWRALELAMSCADPTSARRPTMSHV
VIELKECLVSENSRRNMSRGMDTLSSPEVSMIFDAEMIPRAR*
>AT3G46330.1 | MEE39 (maternal effect embryo arrest 39) kinase
MKNLCWVFLSLFWFGVFLIIRFAEGQNQEGFISLDCGLPLNEPPYIESETGIQFSSDENF
IQSGKTGRIPKNLESENLKQYATLRYFPDGIRNCYDLRVEEGRNYLIRATFFYGNFDGLN
VSPEFDMHIGPNKWTTIDLQIVPDGTVKEIIHIPRSNSLQICLVKTGATIPMISALELRP
LANDTYIAKSGSLKYYFRMYLSNATVLLRYPKDVYDRSWVPYIQPEWNQISTTSNVSNKN
HYDPPQVALKMAATPTNLDAALTMVWRLENPDDQIYLYMHFSEIQVLKANDTREFDIILN
GETINTRGVTPKYLEIMTWLTTNPRQCNGGICRMQLTKTQKSTLPPLLNAFEVYSVLQLP
QSQTNEIEVVAIKNIRTTYGLSRISWQGDPCVPKQFLWDGLNCNITDISAPPRIISLNLS
SSGLSGTIVSNFQNLAHLESLDLSNNSLSGIVPEFLATMKSLLVINLSGNKLSGAIPQAL
RDREREGLKLNVLGNKELCLSSTCIDKPKKKVAVKVVAPVASIAAIVVVILLFVFKKKMS
SRNKPEPWIKTKKKRFTYSEVMEMTKNLQRPLGEGGFGVVYHGDLNGSEQVAVKLLSQTS
AQGYKEFKAEVELLLRVHHINLVNLVGYCDEQDHFALIYEYMSNGDLHQHLSGKHGGSVL
NWGTRLQIAIEAALGLEYLHTGCKPAMVHRDVKSTNILLDEEFKAKIADFGLSRSFQVGG
DQSQVSTVVAGTLGYLDPEYYLTSELSEKSDVYSFGILLLEIITNQRVIDQTRENPNIAE
WVTFVIKKGDTSQIVDPKLHGNYDTHSVWRALEVAMSCANPSSVKRPNMSQVIINLKECL
ASENTRISRNNQNMDSGHSSDQLNVTVTFDTDVKPKAR*
>AT3G03580.1 | pentatricopeptide (PPR) repeat-containing protein
MQTRVSSPFISRALSSSSNLNELRRIHALVISLGLDSSDFFSGKLIDKYSHFREPASSLS
VFRRVSPAKNVYLWNSIIRAFSKNGLFPEALEFYGKLRESKVSPDKYTFPSVIKACAGLF
DAEMGDLVYEQILDMGFESDLFVGNALVDMYSRMGLLTRARQVFDEMPVRDLVSWNSLIS
GYSSHGYYEEALEIYHELKNSWIVPDSFTVSSVLPAFGNLLVVKQGQGLHGFALKSGVNS
VVVVNNGLVAMYLKFRRPTDARRVFDEMDVRDSVSYNTMICGYLKLEMVEESVRMFLENL
DQFKPDLLTVSSVLRACGHLRDLSLAKYIYNYMLKAGFVLESTVRNILIDVYAKCGDMIT
ARDVFNSMECKDTVSWNSIISGYIQSGDLMEAMKLFKMMMIMEEQADHITYLMLISVSTR
LADLKFGKGLHSNGIKSGICIDLSVSNALIDMYAKCGEVGDSLKIFSSMGTGDTVTWNTV
ISACVRFGDFATGLQVTTQMRKSEVVPDMATFLVTLPMCASLAAKRLGKEIHCCLLRFGY
ESELQIGNALIEMYSKCGCLENSSRVFERMSRRDVVTWTGMIYAYGMYGEGEKALETFAD
MEKSGIVPDSVVFIAIIYACSHSGLVDEGLACFEKMKTHYKIDPMIEHYACVVDLLSRSQ
KISKAEEFIQAMPIKPDASIWASVLRACRTSGDMETAERVSRRIIELNPDDPGYSILASN
AYAALRKWDKVSLIRKSLKDKHITKNPGYSWIEVGKNVHVFSSGDDSAPQSEAIYKSLEI
LYSLMAKEGYIPDPREVSQNLEEEEEKRRLICGHSERLAIAFGLLNTEPGTPLQVMKNLR
VCGDCHEVTKLISKIVGREILVRDANRFHLFKDGTCSCKDRW*